Abstract
The COVID-19 pandemic exposed acute tensions in the United Kingdom’s National Health Service (NHS) between its egalitarian self-image and the utilisation of overtly utilitarian tools such as QALY-based cost-effectiveness and prognosis-driven triage. This paper offers a systematic philosophical diagnosis of those tensions through the lens of refined utilitarianism, a consequentialist theory that grounds moral rules in their long-run welfare effects while requiring genuine social approbation and cultural fit. After reconstructing the classical act-/rule-utilitarian debate and engaging canonical critics (Rawls, Scanlon, Dworkin and Williams), the paper distinguishes refined utilitarianism from both rule utilitarianism and prioritarianism, then tests the theory against UK healthcare practice pre- and post-pandemic. Using documentary analysis of NICE technology appraisals, BMA emergency guidance, and statutory equality duties, it is shown that the NHS operates a two-tier code: egalitarian, need-based rules in conditions of routine capacity, and outcome-maximising rules, tempered by fairness safeguards, during acute scarcity. This structure closely matches refined utilitarian predictions: apparently non-utilitarian norms (equal access, prohibition of direct age discrimination, ‘rule of rescue’) are retained because they enhance trust, compliance and therefore aggregate welfare, while harsher maximisation moves (frailty scoring, ICU reallocation, staff testing priority) are publicly justified and time-limited to preserve legitimacy. The analysis answers familiar objections, impracticality of hedonic calculus, neglect of minorities, integrity threats, by showing how socially embedded rules mitigate each problem without surrendering the aim of greatest overall benefit. The paper concludes that UK healthcare is best interpreted as utilitarian in a refined sense, and that refined utilitarianism provides a practicable, normatively attractive template for future resource-allocation frameworks in public health emergencies and beyond.